Underwriting AgreementUnderwriting Agreement • June 30th, 2023 • CorMedix Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2023 Company Industry JurisdictionCorMedix Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, (i) 7,500,000 shares of common stock, $0.001 par value per share (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Shares”) and (ii) pre-funded warrants to purchase up to an aggregate of 2,500,625 shares of Common Stock in the form attached hereto as Exhibit A (the “Pre-Funded Warrants” and, together with the Underwritten Shares, the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 1,500,093 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Shares being hereinafter called the “Shares,” and the Option Securities, together with the Underwritten Securities being hereinafter call
TILRAY BRANDS, INC. $150,000,000 5.20% Convertible Senior Notes due 2027 UNDERWRITING AGREEMENTUnderwriting Agreement • May 31st, 2023 • Tilray Brands, Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledMay 31st, 2023 Company Industry Jurisdiction